BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25786481)

  • 1. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.
    Cao B; Christophersen L; Thomsen K; Sønderholm M; Bjarnsholt T; Jensen PØ; Høiby N; Moser C
    J Antimicrob Chemother; 2015 Jul; 70(7):2057-63. PubMed ID: 25786481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
    Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
    J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments.
    Christophersen L; Schwartz FA; Lerche CJ; Svanekjær T; Kragh KN; Laulund AS; Thomsen K; Henneberg KÅ; Sams T; Høiby N; Moser C
    J Cyst Fibros; 2020 Nov; 19(6):996-1003. PubMed ID: 32067957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.
    Cao B; Christophersen L; Kolpen M; Jensen PØ; Sneppen K; Høiby N; Moser C; Sams T
    PLoS One; 2016; 11(4):e0153616. PubMed ID: 27100887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.
    Bandara HM; Harb A; Kolacny D; Martins P; Smyth HD
    AAPS PharmSciTech; 2014 Dec; 15(6):1644-54. PubMed ID: 25155975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
    Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
    Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P
    Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa.
    Al-Bakri AG; Gilbert P; Allison DG
    J Basic Microbiol; 2005; 45(5):392-6. PubMed ID: 16187262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.
    Maiden MM; Zachos MP; Waters CM
    J Antimicrob Chemother; 2019 Apr; 74(4):894-906. PubMed ID: 30624737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections.
    Noreddin AM; Elkhatib WF
    J Infect Public Health; 2009; 2(3):120-8. PubMed ID: 20701871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
    Du J; Bandara HM; Du P; Huang H; Hoang K; Nguyen D; Mogarala SV; Smyth HD
    Mol Pharm; 2015 May; 12(5):1544-53. PubMed ID: 25793309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
    Chen X; Thomsen TR; Winkler H; Xu Y
    BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
    Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
    Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin.
    Daboor SM; Raudonis R; Cheng Z
    PLoS One; 2021; 16(10):e0258950. PubMed ID: 34695148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.